Description and validation of the apnea risk evaluation system: a novel method to diagnose sleep apnea-hypopnea in the home

ARES had a 0.96 correlation with PSG when recorded concurrently and 0.88 for in-home ARES vs. PSG. ARES demonstrated a sensitivity of 97.4 and a specificity of 85.6 in 284 subjects with data acquired concurrently with PSG, and a sensitivity of 91.5 and a specificity of 85.7 in 187 subjects when comparing in-home recordings to PSG. 32 of 35 of the in-home misclassifications were attributed to differences in the percent time supine. Twenty-percent of the subjects included in this study were healthy controls. The failure rate for the in-home comparisons was only 2%
Description and validation of the apnea risk evaluation system: a novel method to diagnose sleep apnea-hypopnea in the home

More news

Our own Dr. Alyssa Cairns in Sleep Review on undiagnosed Narcolepsy!

Scientists analyze the EEG characteristics of patients with narcolepsy (with and without cataplexy) and idiopathic hypersomnia compared to controls. By Yoona Ha Alyssa Cairns, PhD, a research scientist at SleepMed Inc, talks about her latest sleep research and how there’s a crucial need for developing a better way of identifying patients with narcolepsy that would […]

Importance of mobile data for cPAP compliance

http://mhealthintelligence.com/news/mobile-health-technology-is-breathing-new-life-into-cpap-therapy